Inactive Instrument
Stemcell Holdings, Inc. Share Price Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 24/05/2021 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 16.43L | |
| +1.04% | +10.52% | +34.86% | +0.28% | 7.67TCr | |
| +0.44% | +6.13% | +25.98% | +188.16% | 5.05TCr | |
| +1.02% | +0.81% | -7.73% | +21.83% | 4.85TCr | |
| +1.30% | +3.46% | -50.91% | -49.51% | 4.41TCr | |
| -0.87% | -1.24% | +55.49% | -23.16% | 3.05TCr | |
| -0.66% | -5.74% | +54.13% | +88.28% | 2.43TCr | |
| -1.29% | +3.24% | +104.79% | -48.00% | 2.25TCr | |
| +0.72% | +3.23% | -7.24% | +213.08% | 2TCr | |
| -0.10% | -1.86% | +66.61% | +162.37% | 1.6TCr | |
| Average | +0.16% | -0.38% | +30.67% | +61.48% | 3.7TCr | |
| Weighted average by Cap. | +0.46% | +0.67% | +22.96% | +46.88% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 33.39L 28.92L 26.96L 24.79L 46.8L 32Cr 47.33L 3.17Cr 1.24Cr 16Cr 1.25Cr 1.23Cr 53Cr | 61.8L 53.52L 49.89L 45.89L 86.63L 59Cr 87.6L 5.86Cr 2.3Cr 29Cr 2.32Cr 2.27Cr 97Cr |
| Net income | 14.02L 12.15L 11.32L 10.41L 19.66L 13Cr 19.88L 1.33Cr 52.22L 6.67Cr 52.67L 51.51L 22Cr | 24.1L 20.87L 19.45L 17.89L 33.78L 23Cr 34.16L 2.29Cr 89.73L 11Cr 90.5L 88.51L 38Cr |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
